IGC Pharma (IGC) EBIT Margin Growth (5y) (2015 - 2025)
IGC Pharma (IGC) EBIT Margin Growth (5y) (2015 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
| 10 |
IGC Pharma |
29.33 Mn |
29.07 Mn |
- |
| Date | Value |
|---|
| Sep 30, 2025 |
-17,700.00 |
| Jun 30, 2025 |
-25,014.00 |
| Mar 31, 2025 |
-1.04 Mn |
| Dec 31, 2024 |
-43,789.00 |
| Sep 30, 2024 |
-35,645.00 |
| Jun 30, 2024 |
-79,265.00 |
| Mar 31, 2024 |
152,512.00 |
| Dec 31, 2023 |
-134,681.00 |
| Sep 30, 2023 |
-75,059.00 |
| Jun 30, 2023 |
-35,083.00 |
| Mar 31, 2023 |
314,445.00 |
| Dec 31, 2022 |
-62,407.00 |
| Sep 30, 2022 |
-111,977.00 |
| Jun 30, 2022 |
-57,298.00 |
| Mar 31, 2022 |
552,314.00 |
| Dec 31, 2021 |
-152,501.00 |
| Sep 30, 2021 |
-742,535.00 |
| Jun 30, 2021 |
-273,884.00 |
| Mar 31, 2021 |
504,312.00 |
| Dec 31, 2020 |
-211,914.00 |
